Get an alert when MUREX BIOTECH LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-11-30 (in 6mo)

Last made up 2025-11-16

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

£46M

+3.8% vs 2023

Employees

0

Average over period

Profit before tax

£2M

+14.8% vs 2023

Name history

Renamed 3 times since incorporation

  1. MUREX BIOTECH LIMITED 1996-02-01 → present
  2. MUREX DIAGNOSTICS BRANCHES LIMITED 1992-05-05 → 1996-02-01
  3. BCW BRANCHES LIMITED 1992-01-13 → 1992-05-05
  4. ALNERY NO. 1150 LIMITED 1991-12-12 → 1992-01-13

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover
Operating profit
Profit before tax £2,012,000£2,310,000
Net profit £1,526,000£1,717,000
Cash
Total assets less current liabilities £44,762,000£46,479,000
Net assets £44,762,000£46,479,000
Equity £44,762,000£46,479,000
Average employees 00
Wages £23,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Gearing (liabilities / total assets) 1.0%2.2%
Current ratio 103.90x45.95x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Abridged
Yes — abridged accounts (limited disclosure)
Auditor
Ernst & Young, Chartered Accountants
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Company generated a net profit of £1,717,000 (2023: net profit £1,526,000), has net assets of £46,479,000 (2023: net assets £44,762,000) and current assets of the Company exceed its current liabilities by £46,479,000 (2023: net assets £44,762,000). Interest income is expected to continue in the foreseeable future. Therefore, after making enquiries, the Directors have a reasonable expectation that the Company will continue in operational existence for a period of twelve months from the date of approval of these financial statements.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 54 resigned

Name Role Appointed Born Nationality
GOGAY, Kevan Secretary 2016-09-28
CAMPBELL, Ross Iain Director 2025-04-25 Apr 1976 British
CLAYTON, Michael Robert Kendall Director 2020-03-23 Apr 1974 British
WENNER, James Russell Director 2025-12-10 Sep 1967 American
Show 54 resigned officers
Name Role Appointed Resigned
BROWN, Stephen Secretary 2007-04-02 2007-10-25
DAVIES, Alison Elizabeth Secretary 2000-11-01 2006-09-30
NORRINGTON, Simon Guy Secretary 2007-10-25 2016-06-27
NORRINGTON, Simon Guy Secretary 2006-09-30 2007-04-02
OSBORNE, Charles Fremont Secretary 1996-08-06 1999-02-20
RAMSEY, Steven Charles Secretary 1993-05-10 1996-08-06
ROBERTS, Helen Janet Secretary 1999-02-22 2000-11-01
STRAYER, Richard Dean Secretary 1992-01-13 1992-04-02
WATSON, Michael Alan Secretary 1992-04-23 1993-05-10
ALNERY INCORPORATIONS NO 1 LIMITED Corporate Nominee Secretary 1991-12-12 1992-01-13
BRACKEN, Sharon Jeanne Director 2007-10-25 2008-04-25
BRACKEN, Sharon Jeanne Director 2007-01-19 2007-04-02
BRANIGHAN, Kenneth Robert Director 2001-01-16 2002-12-20
BROWN, Stephen Director 2005-11-30 2006-02-02
BRUSHETT, Samuel Augustine Director 1992-01-13 1993-04-13
CORCORAN, Ciaran Director 2011-09-29 2015-05-31
CORKER, Charles Stanley Director 1992-04-23 1993-01-29
COUGHLAN, Gary Patrick Director 1998-11-30 2001-03-31
CUSICK, Charles Robert Director 1992-01-13 1999-10-01
DAVIES, Alison Elizabeth Director 2023-10-15 2025-12-10
FORREST, Andrew David Hall Director 2005-01-26 2007-10-25
FREYMAN, Thomas Craig Director 2001-03-31 2016-01-29
GUIDETTI, Guido Director 1993-11-01 1999-06-17
HALL, Gary James Director 2015-11-10 2018-09-27
HARRIS, Neil Director 2018-08-31 2025-04-25
HAYWOOD, Mark Director 1998-11-30 2004-07-30
HUDSON, Susan Michelle Director 2016-04-22 2018-08-31
HUNT, Frank Richard Director 1992-01-13 1992-04-23
IGLESIAS FERNANDEZ, Luis Director 2002-12-20 2005-11-30
KRAMMER, Karen Ann Director 2020-03-01 2022-09-19
MARK, David Director 2004-07-22 2004-12-13
MCCOY JR, John Arthur Director 2022-09-19 2023-10-15
MOLITOR, Stefan Norbet Director 2008-04-25 2011-09-29
MORGAN, Peter John, Dr Director 2015-05-13 2016-09-26
MOUNTRICHAS, Georgios Director 2018-09-27 2020-03-23
OSBORNE, Charles Fremont Director 1996-08-06 1999-07-30
PARSONS, William Thomas Director 1995-11-01 1997-11-28
PARTYKA, Kenneth Mark Director 2005-10-21 2007-01-19
RAMSEY, Steven Charles Director 1995-11-01 1999-10-28
RANKIN, John Harry Director 2007-04-02 2008-09-26
REARDON, Thomas Director 2010-08-24 2011-09-29
SCHUELER, John Otto Director 1998-11-30 2001-01-16
SIKORSKI, Jurek Stefan Director 1992-04-23 1993-08-03
SILVESTON, Ronald Peter Director 1992-04-23 2005-12-31
SMITH, Michael James Director 2008-09-26 2015-10-31
STEWART, Jeffrey Ryan Director 2007-10-25 2009-05-02
STRAYER, Richard Dean Director 1992-01-13 1992-04-02
SYMONS, Philip David Frederick Director 1992-01-23 2005-10-21
THOLEN, John David Director 1995-11-01 1997-01-20
WARREN, Frederic Michael Patrick Director 1992-01-13 1999-10-11
WATSON, Michael Alan Director 1992-04-23 1993-05-10
YOOR, Brian Director 2016-01-29 2020-02-29
ALNERY INCORPORATIONS NO 1 LIMITED Corporate Nominee Director 1991-12-12 1992-01-13
ALNERY INCORPORATIONS NO 2 LIMITED Corporate Nominee Director 1991-12-12 1992-01-13

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Abbott Laboratories Ltd Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 210 total filings

Date Type Category Description
2025-12-15 AP01 officers Appoint person director company with name date PDF
2025-12-15 TM01 officers Termination director company with name termination date PDF
2025-11-21 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-09-05 AA accounts Accounts with accounts type full
2025-05-01 AP01 officers Appoint person director company with name date PDF
2025-04-30 TM01 officers Termination director company with name termination date PDF
2024-11-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-22 AA accounts Accounts with accounts type full
2023-11-16 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-10-25 AP01 officers Appoint person director company with name date PDF
2023-10-25 TM01 officers Termination director company with name termination date PDF
2023-08-24 AA accounts Accounts with accounts type full
2022-11-18 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-09-27 AP01 officers Appoint person director company with name date PDF
2022-09-27 TM01 officers Termination director company with name termination date PDF
2022-08-25 AA accounts Accounts with accounts type full
2021-11-18 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-10-07 AA accounts Accounts with accounts type full
2021-09-17 PSC09 persons-with-significant-control Withdrawal of a person with significant control statement PDF
2020-11-18 CS01 confirmation-statement Confirmation statement with no updates PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
5

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page